The company’s inaugural scientific presentation demonstrates how new visual device can improve quality of life for those with age-related macular degeneration (AMD)
(Laguna Beach, CA) April 29, 2018 – Eyedaptic, creators of simulated natural vision software, presented pre-clinical research on a new Augmented Reality (AR) visual aid, designed to improve reading speed and accuracy in individuals with age-related macular degeneration (AMD).
Age-related macular degeneration (AMD) is the leading cause of vision loss for older individuals, impacting more than 170 million people across the globe. The number of those impacted by AMD is expected to increase significantly in the next several years, due to the increased aging of the population.
UCI’s Gavin Herbert Eye Institute Retinal Specialist and Eyedaptic Co-Founder, Mitul Mehta, MD., presented pre-clinical data at the Annual Eye Care Conference on April 29th in Honolulu, Hawaii. As a board-certified ophthalmologist, Dr. Mehta is also the co-founder of the Young Retina Forum as well as the Retinal Section Editor of CSurgeries.com, a surgical education website.
Dr. Mehta’s poster presentation highlighted how Eyedaptic Augmented Reality (AR) visual aids enable improved reading speed and accuracy in individuals with age-related macular degeneration (AMD). Facilitated by augmented reality (AR) glasses, Eyedaptic’s non- invasive mobile visual aid is designed to serve as a practical replacement for low vision devices by completing the user’s field of vision, unlike current visual aids that simply magnify.
I was honored to present this research at the ARVO meeting this year, commented Eyedaptic Chief Medical Officer, Mitul Mehta, MD. The Eyedaptic AR device offers a promising replacement for low vision devices and may serve as a viable part of a low vision rehabilitation plan.
We are excited to provide a comprehensive and adaptive solution that goes above and beyond what is currently available, added Jay Cormier, Founder and CEO of Eyedaptic. At last, users can finally see what they’ve been missing and experience an improved quality of life.
Eyedaptic is a privately held company that develops visual aid software, enabled by augmented reality hardware, for macular degeneration and other retinal diseases. The proprietary Simulated Natural Vision software goes beyond magnification to enable a fuller field of vision, for those suffering from central vision disorders such as AMD (age-related macular degeneration), to revitalize their quality of life. For more information or to request an interview, contact: email@example.com.
The Association for Research in Vision and Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include nearly 11,000 eye and vision researchers from over 75 countries. ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders.
For media inquiries contact: firstname.lastname@example.org